MetLife Investment Management’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $212K | Hold |
|
|||||
|
2025
Q1 | $173K | Sell |
|
|||||
|
2024
Q4 | $283K | Buy |
|
|||||
|
2024
Q3 | $318K | Hold |
|
|||||
|
2024
Q2 | $334K | Buy |
|
|||||
|
2024
Q1 | $416K | Hold |
|
|||||
|
2023
Q4 | $389K | Hold |
|
|||||
|
2023
Q3 | $315K | Hold |
|
|||||
|
2023
Q2 | $354K | Hold |
|
|||||
|
2023
Q1 | $295K | Hold |
|
|||||
|
2022
Q4 | $209K | Hold |
|
|||||
|
2022
Q3 | $183K | Hold |
|
|||||
|
2022
Q2 | $194K | Hold |
|
|||||
|
2022
Q1 | $332K | Buy |
|
|||||
|
2021
Q4 | $274K | Hold |
|
|||||
|
2021
Q3 | $354K | Sell |
|
|||||
|
2021
Q2 | $302K | Hold |
|
|||||
|
2021
Q1 | $369K | Hold |
|
|||||
|
2020
Q4 | $388K | Buy |
|
|||||
|
2020
Q3 | $304K | Buy |
|
|||||
|
2020
Q2 | $282K | Buy |
|